Beech Hill Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-84,075
Closed -$3.52M 82
2016
Q2
$3.52M Buy
+84,075
New +$3.45M 2.38% 20
2015
Q2
Sell
-96,765
Closed -$4.78M 125
2015
Q1
$4.78M Sell
96,765
-1,075
-1% -$51.4K 2.25% 17
2014
Q4
$4.46M Buy
97,840
+13,150
+16% +$638K 2.22% 19
2014
Q3
$4.78M Buy
84,690
+4,685
+6% +$252K 2.26% 16
2014
Q2
$4.25M Buy
80,005
+7,180
+10% +$381K 1.87% 23
2014
Q1
$3.81M Buy
72,825
+1,575
+2% +$79.7K 1.79% 26
2013
Q4
$3.82M Sell
71,250
-675
-0.9% -$34.8K 1.93% 21
2013
Q3
$3.64M Buy
71,925
+13,350
+23% +$679K 1.97% 22
2013
Q2
$3.02M Buy
+58,575
New +$3.12M 1.71% 27

Other funds holding SNY

Beech Hill Advisors's SNY Position: Q3 2016 in Review

Beech Hill Advisors sold out of Sanofi (SNY) in Q3 2016, closing a stake of 84,075 shares — an estimated $3.52M sold.

Beech Hill Advisors first reported a position in SNY in Q2 2013 and held it in 9 quarters. The position peaked at $4.78M in Q1 2015. 449 funds tracked by Wall St. Rank hold SNY as of Q3 2016.

  • Beech Hill Advisors reported no remaining Sanofi position as of Q3 2016 after selling out during the quarter.
  • Beech Hill Advisors sold 84,075 Sanofi shares in Q3 2016, an estimated $3.52M.
  • Beech Hill Advisors first reported a position in Sanofi in Q2 2013 and held it in 9 quarters.
  • Beech Hill Advisors's Sanofi position peaked at $4.78M in Q1 2015.
  • 449 funds tracked by Wall St. Rank held Sanofi as of Q3 2016.

Based on Beech Hill Advisors's 13F filing for Q3 2016, filed 21 Oct 2016.